Related Experiment Video
Updated: Aug 18, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia
R Nemni1, L Sanvito, A Quattrini
1Department of Neurorehabilitation, IRCCS Don C Gnocchi Foundation, University of Milan, Italy. raffaello.nemni@unimi.it
Insights
Hepatitis C virus (HCV) infection is linked to cryoglobulinemia (CG), increasing peripheral neuropathy (PN) risk. Nerve damage in HCV-associated CG and PN appears ischemic, not directly viral.
Area of Science:
- Hepatology
- Neurology
- Immunology
Background:
- Hepatitis C virus (HCV) infection frequently co-occurs with cryoglobulinemia (CG).
- Peripheral neuropathy (PN) is a known complication of HCV-associated CG, often attributed to nerve ischemia.
- Recent findings suggest a potential direct role of HCV in PN pathogenesis.
Purpose of the Study:
- To determine the prevalence of CG in HCV patients.
- To clarify the mechanism by which HCV contributes to PN.
- To assess the relationship between CG and PN in HCV infection.
Main Methods:
- Clinical, laboratory, and electrophysiological assessments of 51 HCV patients.
- Sural nerve biopsy with morphological and morphometric evaluation in 28 patients.
- Statistical analysis of clinical and pathological findings.
Main Results:
- Cryoglobulinemia (CG) was detected in 78% of HCV patients.
- Polyneuropathy was significantly more common in patients with CG (40%) compared to those without (11%).
- Nerve biopsies revealed ischemic nerve damage in both CG+ and CG- patients, with more severe involvement in CG+ cases.
Conclusions:
- Cryoglobulinemia (CG) presence is a negative predictive factor for associated peripheral neuropathy (PN) in HCV infection.
- Morphological findings support an ischemic mechanism for nerve damage.
- Evidence does not support a direct viral role of HCV in causing PN.
Objectives:
Hepatitis C virus (HCV) infection is often associated with cryoglobulinaemia (CG). Peripheral neuropathy (PN) is a comparatively common complication of CG associated with HCV infection and it is thought to be attributable to nerve ischaemia. Only few HCV CG patients with PN have been reported. The recent finding of HCV RNA in nerve biopsy specimens has suggested a possible direct role of HCV in the pathogenesis of PN. The authors studied 51 HCV patients to determine the prevalence of CG and to clarify the possible mechanism by which HCV determines the PN.
Methods:
All the patients were studied clinically, by laboratory tests and electrophysiologically. Twenty eight patients underwent sural nerve biopsy where both morphological and morphometric evaluation of the biopsy specimen was performed, as well as statistical analysis.
Results:
CG was found in 40 of 51 cases (78%). Polyneuropathy was significantly prevalent in CG+ patients compared with CG- (18 of 40 compared with 1 of 11 patients; p=0.01). HCV CG- patients more frequently developed well defined mononeuropathy or multiple neuropathy when compared with HCV CG+ (10 of 11 compared with 22 of 40; p<0.03). HCV CG+ patients showed significantly higher proportion of rheumatoid factor positivity (p<0.001) and low C4 levels (p=0.001). Nerve biopsy was performed in 25 of 40 HCV CG+ patients and in 3 of 11 HCV CG- patients: epineurial vasculitis was present in 8 of 25 HCV CG+ (32%) and in 2 of 3 HCV CG-. Differential fascicular loss of axons was found in 10 of 25 CG+ (40%) and 1 of 3 CG-, signs of both demyelination and axonal degeneration were present in 7 of 25 CG+ (28%). No significant difference was found in neuropathological features, while histometrical analysis disclosed more severe involvement in CG+ patients.
Conclusions:
These findings suggest that the presence of CG is a negative predictive factor for the associated PN. Morphological findings in the sural nerve from HCV CG- and CG+ are consistent with an ischaemic mechanism of nerve damage and are against a direct role of the virus in causing the associated PN.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Hepatitis
Diabetic Neuropathy
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

